Picture of Daesung Microbiological Labs Co logo

036480 Daesung Microbiological Labs Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Daesung Microbiological Labs Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsARSAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line2,8501,5198661,703-680
Depreciation
Amortisation
Non-Cash Items7541,309453-919703
Accounting Change
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-2,398-1,539-1,654-2,335-4,120
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities2,3153,2362,2031,155-1,234
Capital Expenditures-11,575-14,444-2,969-2,315-1,260
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items1,810-1,128-6721,1571,496
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-9,764-15,572-3,641-1,158236
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities10,6959,558305-6461,481
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash3,309-3,040-817-543511